BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38048308)

  • 1. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    Yuk JS; Park JY
    PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study.
    Yuk JS; Lee JS; Park JH
    Front Aging Neurosci; 2023; 15():1213481. PubMed ID: 37744387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS
    Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.
    Yuk JS; Kim BY
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
    Yuk JS; Jeong SH
    J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy with conjugated equine estrogen is associated with a higher risk of hemorrhagic stroke than therapy with estradiol: a retrospective population-based cohort study.
    Chang WC; Wang JH; Ding DC
    Maturitas; 2022 Nov; 165():72-77. PubMed ID: 35933795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy and the risk of cataracts in postmenopausal women in South Korea.
    Yuk JS; Park JY; Sim HE; Hwang JH
    Ophthalmic Physiol Opt; 2023 Mar; 43(2):254-262. PubMed ID: 36609995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
    Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
    Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer risk of menopausal hormone therapy in a Korean cohort.
    Yuk JS; Lee SK; Uh JA; Seo YS; Kim M; Kim MS
    Sci Rep; 2023 Jun; 13(1):10572. PubMed ID: 37386069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea.
    Yuk JS; Seo YS; Im YH; Kim JH
    Semin Arthritis Rheum; 2023 Dec; 63():152280. PubMed ID: 37857046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
    Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
    Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hugon-Rodin J; Perol S; Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.